 12. Any other malignancy within 5 years prior to enrollment, with the exception of adequately treated in-situ carcinoma of the prostate Gleason score 7, cervix, uteri, or nonmelanomatous skin cancer all treatment of which should have been completed 6 months prior to enrollment. 